Literature DB >> 2195455

[Direct effect of nitroxoline in the inhibition of bacterial adherence to urinary catheters].

L Oliviero1, M Perdiz, P Bourlioux.   

Abstract

Nitroxolin or 5-nitro-8-hydroxyquinoline, used in the treatment of acute or recurrent uncomplicated urinary tract infection, has been investigated to demonstrate direct inhibitory effect on Escherichia coli adherence to solid surfaces. First of all, influence of growth medium on bacterial adherence was studied. No relation occurs between growth media enhancing production of adhesins and the ability to adhere to solid surfaces. While bacteria are grown on minimal medium, nitroxolin (MIC/16 to MIC/4) can significantly reduce bacterial adherence to urinary catheter of uropathogenic strains of Escherichia coli AL52 and 382. Increasing the concentration of nitroxolin does not proportionally modify this decrease. When growth is realised on LB broth or agar, nitroxolin does not affect bacterial adherence of strain AL52 and higher doses (8 to 32 mg.l-1) are necessary to obtain the same inhibition of adherence of strain 382. Nitroxolin, in certain conditions, can, directly and rapidly, reduce bacterial adherence to solid surfaces.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2195455

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  4 in total

1.  [Nitroxoline - an option for the antibiotic treatment of urinary tract infections].

Authors:  H Hof; D Bertsch; D Passek; R Schwarz
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

2.  In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis.

Authors:  Ada Marie Hoffmann; Martina Wolke; Jan Rybniker; Georg Plum; Frieder Fuchs
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

3.  Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers.

Authors:  Florian M E Wagenlehner; Fabian Münch; Adrian Pilatz; Birte Bärmann; Wolfgang Weidner; Christine M Wagenlehner; Marion Straubinger; Holger Blenk; Wolfgang Pfister; Michael Kresken; Kurt G Naber
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

Review 4.  Review of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections.

Authors:  Kurt G Naber; Hiltrud Niggemann; Gisela Stein; Guenter Stein
Journal:  BMC Infect Dis       Date:  2014-11-27       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.